<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33913406</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-6190</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Current neuropharmacology</Title><ISOAbbreviation>Curr Neuropharmacol</ISOAbbreviation></Journal><ArticleTitle>Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update.</ArticleTitle><Pagination><StartPage>179</StartPage><EndPage>193</EndPage><MedlinePgn>179-193</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1570159X19666210428120514</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a motor neuron disease (MND) that typically causes death within 3-5 years after diagnosis. Regardless of the substantial scientific knowledge accrued more than a century ago, truly effective therapeutic strategies remain distant. Various conventional drugs are being used but are having several adverse effects.</AbstractText><AbstractText Label="OBJECTIVE/AIM" NlmCategory="OBJECTIVE">The current study aims to thoroughly review plant-derived compounds with welldefined ALS activities and their structure-activity relationships. Moreover, the review also focuses on complex genetics, clinical trials, and the use of natural products that might decrypt the future and novel therapeutics in ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The collection of data for the compilation of this review work was searched in PubMed Scopus, Google Scholar, and Science Direct.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Results showed that phytochemicals like-Ginkgolides, Protopanaxatriol, Genistein, epigallocatechingallate, resveratrol, cassoside, and others possess Amyotrophic lateral sclerosis (ALS) activity by various mechanisms Conclusion: These plant-derived compounds may be considered as supplements for conventional (ALS). Moreover, further preclinical and clinical studies are required to understand the structureactivity relationships, metabolism, absorption, and mechanisms of plant-derived natural agents.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohi-Ud-Din</LastName><ForeName>Roohi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pharmacognosy &amp; Phytochemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, Kashmir,India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mir</LastName><ForeName>Reyaz Hassan</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Pharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar-190006, Kashmir,India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Abdul Jalil</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Pharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar-190006, Kashmir,India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabreen</LastName><ForeName>Saba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar-190006, Kashmir,India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wani</LastName><ForeName>Taha Umair</ForeName><Initials>TU</Initials><AffiliationInfo><Affiliation>Pharmaceutics Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar-190006, Kashmir,India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masoodi</LastName><ForeName>Mubashir Hussain</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Pharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar-190006, Kashmir,India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akkol</LastName><ForeName>Esra K&#xfc;peli</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330, Ankara,Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhat</LastName><ForeName>Zulfiqar Ali</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>Pharmacognosy &amp; Phytochemistry Division, Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal, Srinagar, 190006, Kashmir,India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Haroon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Abdul Wali Khan University, Mardan, 23200,Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Neuropharmacol</MedlineTA><NlmUniqueID>101157239</NlmUniqueID><ISSNLinking>1570-159X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CNS disorders</Keyword><Keyword MajorTopicYN="N">Plant-derived products</Keyword><Keyword MajorTopicYN="N">SAR</Keyword><Keyword MajorTopicYN="N">SOD1 mutations</Keyword><Keyword MajorTopicYN="N">Therapeutic effects</Keyword><Keyword MajorTopicYN="N">clinical trials</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>29</Day><Hour>8</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33913406</ArticleId><ArticleId IdType="pmc">PMC9199545</ArticleId><ArticleId IdType="doi">10.2174/1570159X19666210428120514</ArticleId><ArticleId IdType="pii">CN-EPUB-115508</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nat. Rev. Neurosci. 2006;7(9):710&#x2013;723. doi: 10.1038/nrn1971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1971</ArticleId><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V., Islam A., Hassan M.I., Ahmad F. Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning. Eur. J. Med. Chem. 2016;121:903&#x2013;917. doi: 10.1016/j.ejmech.2016.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2016.06.017</ArticleId><ArticleId IdType="pubmed">27372371</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil J., Funalot B., Verschueren A., Danel-Brunaud V., Camu W., Vandenberghe N., Desnuelle C., Guy N., Camdessanche J.P., Cintas P., Carluer L., Pittion S., Nicolas G., Corcia P., Fleury M.C., Maugras C., Besson G., Le Masson G., Couratier P. Causes of death amongst French patients with amyotrophic lateral sclerosis: A prospective study. Eur. J. Neurol. 2008;15(11):1245&#x2013;1251. doi: 10.1111/j.1468-1331.2008.02307.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02307.x</ArticleId><ArticleId IdType="pubmed">18973614</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R., Lo Re M., Piccoli T., Piccoli F., La Bella V. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol. Scand. 2010;122(3):217&#x2013;223. doi: 10.1111/j.1600-0404.2009.01290.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2009.01290.x</ArticleId><ArticleId IdType="pubmed">20078446</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14(4):248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradas J., Puig T., Rojas-Garc&#xed;a R., Viguera M.L., Gich I., Logroscino G. Amyotrophic lateral sclerosis in Catalonia: A population based study. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013;14(4):278&#x2013;283. doi: 10.3109/21678421.2012.749915.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.749915</ArticleId><ArticleId IdType="pubmed">23286747</ArticleId></ArticleIdList></Reference><Reference><Citation>Joensen P. Incidence of amyotrophic lateral sclerosis in the Faroe Islands. Acta Neurol. Scand. 2012;126(1):62&#x2013;66. doi: 10.1111/j.1600-0404.2011.01611.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2011.01611.x</ArticleId><ArticleId IdType="pubmed">22034926</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Traynor B.J., Collins J., Simeone J.C., Goldstein L.A., White L.A. Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature. Neuroepidemiology. 2013;41(2):118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittie M., Nelson L.M., Usher S., Ward K., Benatar M. Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainment. Neuroepidemiology. 2013;40(2):133&#x2013;141. doi: 10.1159/000342156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000342156</ArticleId><ArticleId IdType="pubmed">23095852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufir&#xed;a M., Gil-Bea F.J., Fern&#xe1;ndez-Torr&#xf3;n R., Poza J.J., Mu&#xf1;oz-Blanco J.L., Rojas-Garc&#xed;a R., Riancho J., L&#xf3;pez de Munain A. ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog. Neurobiol. 2016;142:104&#x2013;129. doi: 10.1016/j.pneurobio.2016.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.05.004</ArticleId><ArticleId IdType="pubmed">27236050</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chi&#xf2; A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E. Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81(4):385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaldivar T., Gutierrez J., Lara G., Carbonara M., Logroscino G., Hardiman O. Reduced frequency of ALS in an ethnically mixed population: A population-based mortality study. Neurology. 2009;72(19):1640&#x2013;1645. doi: 10.1212/WNL.0b013e3181a55f7b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a55f7b</ArticleId><ArticleId IdType="pubmed">19433736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011;7(11):616&#x2013;630. doi: 10.1038/nrneurol.2011.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.152</ArticleId><ArticleId IdType="pubmed">22051914</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw P.J. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J. Neurol. Neurosurg. Psychiatry. 2005;76(8):1046&#x2013;1057. doi: 10.1136/jnnp.2004.048652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2004.048652</ArticleId><ArticleId IdType="pmc">PMC1739758</ArticleId><ArticleId IdType="pubmed">16024877</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunkel P., Chai C.L., Sperl&#xe1;gh B., Huleatt P.B., M&#xe1;tyus P. Clinical utility of neuroprotective agents in neurodegenerative diseases: Current status of drug development for Alzheimer&#x2019;s, Parkinson&#x2019;s and Huntington&#x2019;s diseases, and amyotrophic lateral sclerosis. Expert Opin. Investig. Drugs. 2012;21(9):1267&#x2013;1308. doi: 10.1517/13543784.2012.703178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543784.2012.703178</ArticleId><ArticleId IdType="pubmed">22741814</ArticleId></ArticleIdList></Reference><Reference><Citation>Contestabile A. Amyotrophic lateral sclerosis: From research to therapeutic attempts and therapeutic perspectives. Curr. Med. Chem. 2011;18(36):5655&#x2013;5665. doi: 10.2174/092986711798347289.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986711798347289</ArticleId><ArticleId IdType="pubmed">22172070</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A., Al-Mohanna F., Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 2011;70(6):913&#x2013;919. doi: 10.1002/ana.22534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2014;10(11):661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Walsh C., Lynch C., Bede P., Elamin M., Kenna K., McLaughlin R., Hardiman O. Rate of familial amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2011;82(6):623&#x2013;627. doi: 10.1136/jnnp.2010.224501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.224501</ArticleId><ArticleId IdType="pubmed">21047878</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Hardiman O. The epidemiology of ALS: A conspiracy of genes, environment and time. Nat. Rev. Neurol. 2013;9(11):617&#x2013;628. doi: 10.1038/nrneurol.2013.203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagoshi N., Nakashima H., Fehlings M.G. Riluzole as a neuroprotective drug for spinal cord injury: From bench to bedside. Molecules. 2015;20(5):7775&#x2013;7789. doi: 10.3390/molecules20057775.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules20057775</ArticleId><ArticleId IdType="pmc">PMC6272473</ArticleId><ArticleId IdType="pubmed">25939067</ArticleId></ArticleIdList></Reference><Reference><Citation>Glicksman M.A. The preclinical discovery of amyotrophic lateral sclerosis drugs. Expert Opin. Drug Discov. 2011;6(11):1127&#x2013;1138. doi: 10.1517/17460441.2011.628654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17460441.2011.628654</ArticleId><ArticleId IdType="pmc">PMC3367799</ArticleId><ArticleId IdType="pubmed">22646982</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz M.P. Edaravone (Radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis. P&amp;T. 2018;43(1):25&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5737249</ArticleId><ArticleId IdType="pubmed">29290672</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Aoki M., Tsuji S., Itoyama Y., Sobue G., Togo M., Hamada C., Tanaka M., Akimoto M., Nakamura K. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16(7):505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir R.H., Sawhney G., Verma R., Ahmad B., Kumar P., Ranjana S., Bhagat A., Madishetti S., Ahmed Z., Jachak S.M. Oreganum Vulgare: In-vitro assessment of cytotoxicity, Molecular docking studies, Antioxidant, and evaluation of anti-inflammatory activity in LPS stimulated RAW 264.7 cells. Medicinal Chemistry: Shariqah, United Arab Emirates, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32885758</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan Mir R., Godavari G., Siddiqui N.A., Ahmad B., Mothana R.A., Ullah R., Almarfadi O.M., Jachak S.M., Masoodi M.H. Design, synthesis, molecular modelling, and biological evaluation of oleanolic acid-arylidene derivatives as potential anti-inflammatory agents. Drug Des. Devel. Ther. 2021;15:385&#x2013;397. doi: 10.2147/DDDT.S291784.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S291784</ArticleId><ArticleId IdType="pmc">PMC7871991</ArticleId><ArticleId IdType="pubmed">33574657</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohi-Ud-Din R., Mir R.H., Mir P.A., Farooq S., Raza S.N., Raja W.Y., Masoodi M.H., Singh I.P., Bhat Z.A. Ethnomedicinal uses, phytochemistry and pharmacological aspects of the genus berberis linn: A comprehensive review. Comb. Chem. High Throughput Screen. 2021;24(5):624&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">33143603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir R.H., Bhat M.F., Sawhney G., Kumar P., Andrabi N.I., Shaikh M., Mohi-Ud-Din R., Masoodi M.H. Prunella vulgaris L: Critical pharmacological, expository traditional uses and extensive phytochemistry: A review. Curr. Drug Discov. Technol. 2021 doi: 10.2174/1570163818666210203181542.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570163818666210203181542</ArticleId><ArticleId IdType="pubmed">33538676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan R., Masoodi M.H. Saussurea lappa: A comprehensive review on its pharmacological activity and phytochemistry. Curr. Tradit. Med. 2020;6(1):13&#x2013;23. doi: 10.2174/2215083805666190626144909.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/2215083805666190626144909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir R.H., Masoodi M.H. Anti-inflammatory plant polyphenolics and cellular action mechanisms. Curr. Bioact. Compd. 2020;16(6):809&#x2013;817. doi: 10.2174/1573407215666190419205317.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573407215666190419205317</ArticleId></ArticleIdList></Reference><Reference><Citation>Rates S.M.K. Plants as source of drugs. Toxicon. 2001;39(5):603&#x2013;613. doi: 10.1016/S0041-0101(00)00154-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0041-0101(00)00154-9</ArticleId><ArticleId IdType="pubmed">11072038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir R.H., Shah A.J., Mohi-Ud-Din R., Pottoo F.H., Dar M.A., Jachak S.M., Masoodi M.H. Natural anti-inflammatory compounds as drug candidates in Alzheimer&#x2019;s disease. Curr. Med. Chem. 2020;28(23):4799&#x2013;4825. doi: 10.2174/0929867327666200730213215.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867327666200730213215</ArticleId><ArticleId IdType="pubmed">32744957</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Raamsdonk J.M., Vega I.E., Brundin P. Oxidative stress in neurodegenerative disease: Causation or association? Oncotarget. 2017;8(7):10777&#x2013;10778. doi: 10.18632/oncotarget.14650.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.14650</ArticleId><ArticleId IdType="pmc">PMC5355220</ArticleId><ArticleId IdType="pubmed">28099897</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Zhou T., Ziegler A.C., Dimitrion P., Zuo L. Oxidative stress in neurodegenerative diseases: From molecular mechanisms to clinical applications. Oxid. Med. Cell. Longev. 2017;2017:2525967. doi: 10.1155/2017/2525967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/2525967</ArticleId><ArticleId IdType="pmc">PMC5529664</ArticleId><ArticleId IdType="pubmed">28785371</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Kukreti R., Saso L., Kukreti S. Oxidative stress: A key modulator in neurodegenerative diseases. Molecules. 2019;24(8):1583. doi: 10.3390/molecules24081583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24081583</ArticleId><ArticleId IdType="pmc">PMC6514564</ArticleId><ArticleId IdType="pubmed">31013638</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekatsina M., Paladini A., Piroli A., Zis P., Pergolizzi J.V., Varrassi G. Pathophysiology and therapeutic perspectives of oxidative stress and neurodegenerative diseases: A narrative review. Adv. Ther. 2020;37(1):113&#x2013;139. doi: 10.1007/s12325-019-01148-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-019-01148-5</ArticleId><ArticleId IdType="pmc">PMC6979458</ArticleId><ArticleId IdType="pubmed">31782132</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui K. Reactive oxygen species induce neurite degeneration before induction of cell death. J. Clin. Biochem. Nutr. 2016;59(3):155&#x2013;159. doi: 10.3164/jcbn.16-34.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.16-34</ArticleId><ArticleId IdType="pmc">PMC5110939</ArticleId><ArticleId IdType="pubmed">27895381</ArticleId></ArticleIdList></Reference><Reference><Citation>Forni C., Facchiano F., Bartoli M., Pieretti S., Facchiano A., D&#x2019;Arcangelo D., Norelli S., Valle G., Nisini R., Beninati S. Beneficial role of phytochemicals on oxidative stress and age-related diseases. BioMed Res. Int. 2019;7:8748253. doi: 10.1155/2019/8748253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/8748253</ArticleId><ArticleId IdType="pmc">PMC6475554</ArticleId><ArticleId IdType="pubmed">31080832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chico L., Ienco E.C., Bisordi C., Lo Gerfo A., Petrozzi L., Petrucci A., Mancuso M., Siciliano G. Amyotrophic Lateral Sclerosis and oxidative stress: A double-blind therapeutic trial after curcumin supplementation. CNS Neurol. Disord. Drug Targets. 2018;17(10):767&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pubmed">30033879</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai J-R., Liu Y-J., Song Y. The mechanism of interfere effects of madecassoside (MC) on neurodegeneration in mice. Zhongguo Laonianxue Zazhi. 2008;28:2297&#x2013;2300.</Citation></Reference><Reference><Citation>Kobayashi Y., Liu Y., Tobinaga S., Tsunematsu T., Nakamura M. In journal of pharmacological sciences.Japanese pharmacological soc editorial off, kantohya bldg gokomachi, 2007, 103, 136.</Citation></Reference><Reference><Citation>Liu Y. Therapeutic potential of madecassoside in transgenic mice of amyotrophic lateral sclerosis. Chinese Traditional Herbal Drugs. 1994:5.</Citation></Reference><Reference><Citation>Liu S., Li G., Tang H., Pan R., Wang H., Jin F., Yan X., Xing Y., Chen G., Fu Y., Dong J. Madecassoside ameliorates lipopolysaccharide-induced neurotoxicity in rats by activating the Nrf2-HO-1 pathway. Neurosci. Lett. 2019;709:134386. doi: 10.1016/j.neulet.2019.134386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134386</ArticleId><ArticleId IdType="pubmed">31330225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V., Preeti G., Md Imtaiyaz H. Mechanism and implications of traditional Chinese medicine in amyotrophic lateral sclerosis therapy. J. Proteins Proteom. 2019;10(2):131&#x2013;147.</Citation></Reference><Reference><Citation>Kambara T., Zhou Y., Oda M., Tamura Y., Miyakoshi M., Mizutani K., Ikeda T., Tanaka O., Chou W. 120th Annual Meeting of Pharmaceutical Society of Japan; Gifu. 2000.</Citation></Reference><Reference><Citation>Murakami T., Miyakoshi M., Araho D., Mizutani K., Kambara T., Ikeda T., Chou W-H., Inukai M., Takenaka A., Igarashi K. Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. Biofactors. 2004;21(1-4):175&#x2013;178. doi: 10.1002/biof.552210136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.552210136</ArticleId><ArticleId IdType="pubmed">15630194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kou X., Shen K., An Y., Qi S., Dai W.X., Yin Z. Ampelopsin inhibits H2O2-induced apoptosis by ERK and Akt signaling pathways and up-regulation of heme oxygenase-1. Phytother. Res. 2012;26(7):988&#x2013;994. doi: 10.1002/ptr.3671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.3671</ArticleId><ArticleId IdType="pubmed">22144097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.Y., Leem E., Lee J.M., Kim S.R. Control of reactive oxygen species for the prevention of parkinson&#x2019;s disease: The possible application of flavonoids. Antioxidants. 2020;9(7):583. doi: 10.3390/antiox9070583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9070583</ArticleId><ArticleId IdType="pmc">PMC7402123</ArticleId><ArticleId IdType="pubmed">32635299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel S., Weinreb O., Amit T., Youdim M.B. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: Implications for neurodegenerative diseases. J. Neurochem. 2004;88(6):1555&#x2013;1569. doi: 10.1046/j.1471-4159.2003.02291.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.02291.x</ArticleId><ArticleId IdType="pubmed">15009657</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh S-H., Lee S.M., Kim H.Y., Lee K-Y., Lee Y.J., Kim H-T., Kim J., Kim M-H., Hwang M.S., Song C., Yang K.W., Lee K.W., Kim S.H., Kim O.H. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci. Lett. 2006;395(2):103&#x2013;107. doi: 10.1016/j.neulet.2005.10.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2005.10.056</ArticleId><ArticleId IdType="pubmed">16356650</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Chen S., Li X., Luo G., Li L., Le W. Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem. Res. 2006;31(10):1263&#x2013;1269. doi: 10.1007/s11064-006-9166-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-006-9166-z</ArticleId><ArticleId IdType="pubmed">17021948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hockenbery D.M., Oltvai Z.N., Yin X-M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75(2):241&#x2013;251. doi: 10.1016/0092-8674(93)80066-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)80066-N</ArticleId><ArticleId IdType="pubmed">7503812</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi S.F., Daglia M., D&#x2019;Antona G., Sobarzo-S&#xe1;nchez E., Talas Z.S., Nabavi S.M. Natural compounds used as therapies targeting to amyotrophic lateral sclerosis. Curr. Pharm. Biotechnol. 2015;16(3):211&#x2013;218. doi: 10.2174/1389201016666150118132224.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389201016666150118132224</ArticleId><ArticleId IdType="pubmed">25601606</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan E., Rajasekaran R. Probing the inhibitory activity of epigallocatechin-gallate on toxic aggregates of mutant (L84F) SOD1 protein through geometry based sampling and steered molecular dynamics. J. Mol. Graph. Model. 2017;74:288&#x2013;295. doi: 10.1016/j.jmgm.2017.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmgm.2017.04.019</ArticleId><ArticleId IdType="pubmed">28458007</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher P. The potential of flavonoids for the treatment of neurodegenerative diseases. Int. J. Mol. Sci. 2019;20(12):3056. doi: 10.3390/ijms20123056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20123056</ArticleId><ArticleId IdType="pmc">PMC6627573</ArticleId><ArticleId IdType="pubmed">31234550</ArticleId></ArticleIdList></Reference><Reference><Citation>Solanki I., Parihar P., Parihar M.S. Neurodegenerative diseases: From available treatments to prospective herbal therapy. Neurochem. Int. 2016;95:100&#x2013;108. doi: 10.1016/j.neuint.2015.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2015.11.001</ArticleId><ArticleId IdType="pubmed">26550708</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Matsunaga K., Ohizumi Y. Nerve growth factor-potentiating compounds from picrorhizae rhizoma. Biol. Pharm. Bull. 2000;23(7):890&#x2013;892. doi: 10.1248/bpb.23.890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.23.890</ArticleId><ArticleId IdType="pubmed">10919373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Liu J.W., Yu Y.J., Zheng P.Y., Zhang X.D., Li T., Guo M.C. Synergistic protective effect of picroside II and NGF on PC12 cells against oxidative stress induced by H2O2. Pharmacol. Rep. 2007;59(5):573&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">18048958</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Liu J-W., Zhang X-D., Guo M-C., Ji G. The neuroprotective effect of picroside II from hu-huang-lian against oxidative stress. Am. J. Chin. Med. 2007;35(4):681&#x2013;691. doi: 10.1142/S0192415X0700517X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1142/S0192415X0700517X</ArticleId><ArticleId IdType="pubmed">17708634</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo N., Jin C., Shen L., Wu F., Lin X., Feng Y. Chemical components, pharmacological actions, and clinical applications of Rhizoma Picrorhizae. Phytother. Res. 2020;34(5):1071&#x2013;1082. doi: 10.1002/ptr.6591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6591</ArticleId><ArticleId IdType="pubmed">31880854</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Xu J., Li L., Wang P., Ji X., Ai H., Zhang L., Li L. Neuroprotective effect of morroniside on focal cerebral ischemia in rats. Brain Res. Bull. 2010;83(5):196&#x2013;201. doi: 10.1016/j.brainresbull.2010.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2010.07.003</ArticleId><ArticleId IdType="pubmed">20637265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Huang W., Li L., Ai H., Sun F., Liu C., An Y. Morroniside prevents peroxide-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells. Cell. Mol. Neurobiol. 2008;28(2):293&#x2013;305. doi: 10.1007/s10571-007-9168-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-007-9168-7</ArticleId><ArticleId IdType="pubmed">17647102</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Sun F., An Y., Ai H., Zhang L., Huang W., Li L. Morroniside protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide-induced cytotoxicity. Eur. J. Pharmacol. 2009;613(1-3):19&#x2013;23. doi: 10.1016/j.ejphar.2009.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2009.04.013</ArticleId><ArticleId IdType="pubmed">19379729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J-X., Wang R., Xi J., Shen L., Zhu A-Y., Qi Q., Wang Q-Y., Zhang L-J., Wang F-C., L&#xfc; H-Z., Hu J.G. Morroniside protects SK-N-SH human neuroblastoma cells against H2O2-induced damage. Int. J. Mol. Med. 2017;39(3):603&#x2013;612. doi: 10.3892/ijmm.2017.2882.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2017.2882</ArticleId><ArticleId IdType="pmc">PMC5360361</ArticleId><ArticleId IdType="pubmed">28204825</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Lin B., Lin D. Effects of morroniside on the viability of random skin flaps in rats. J. Invest. Surg. 2020;33(2):182&#x2013;188. doi: 10.1080/08941939.2018.1479007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08941939.2018.1479007</ArticleId><ArticleId IdType="pubmed">29869899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Shi-bo.; Jing-fu, Qiu.; Qun-hua, B.; Jia-Jia, Li.; Jin-yu, He.; Yan-jun G.; and Chao Y. A study on protection of astragaioside IV about oxidative stress on PC12 cells induced by H2O2. Chinese Pharmacol. Bull., 2011;11</Citation></Reference><Reference><Citation>Rong J., Cheung C.Y-H., Lau A.S-Y., Shen J., Tam P.K-H., Cheng Y-C. Induction of heme oxygenase-1 by traditional Chinese medicine formulation ISF-1 and its ingredients as a cytoprotective mechanism against oxidative stress. Int. J. Mol. Med. 2008;21(4):405&#x2013;411. doi: 10.3892/ijmm.21.4.405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.21.4.405</ArticleId><ArticleId IdType="pubmed">18360685</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Guo M., Li Y., Zhang H., Chai Z., Wang Q., Yan Y., Yu J., Liu C., Zhang G-X. Astragaloside IV protects neurons from microglia-mediated cell damage through promoting microglia polarization. Folia Neuropathol. 2019;57(2):170&#x2013;181. doi: 10.5114/fn.2019.86299.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2019.86299</ArticleId><ArticleId IdType="pubmed">31556576</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahzad M., Shabbir A., Wojcikowski K., Wohlmuth H., Gobe G.C. The antioxidant effects of Radix Astragali (Astragalus membranaceus and related species) in protecting tissues from injury and disease. Curr. Drug Targets. 2016;17(12):1331&#x2013;1340. doi: 10.2174/1389450116666150907104742.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450116666150907104742</ArticleId><ArticleId IdType="pubmed">26343107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Shen L., Lin X., Hong Y., Feng Y. Clinical research on traditional chinese medicine compounds and their preparations for amyotrophic lateral sclerosis. Biomed. Pharmacother. 2017;96:854&#x2013;864. doi: 10.1016/j.biopha.2017.09.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.09.135</ArticleId><ArticleId IdType="pubmed">29078263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M-M., Bu H., Li B., Yu J-X., Guo Y-S., Li C-Y. Neuroprotective potential of phase II enzyme inducer diallyl trisulfide. Neurol. Res. 2009;31(1):23&#x2013;27. doi: 10.1179/174313208X332959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/174313208X332959</ArticleId><ArticleId IdType="pubmed">18768114</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Zhang K., Wang Q., Li Z., Yin Y., Xu Q., Duan W., Li C. Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Brain Res. 2011;1374:110&#x2013;115. doi: 10.1016/j.brainres.2010.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.12.014</ArticleId><ArticleId IdType="pubmed">21147075</ArticleId></ArticleIdList></Reference><Reference><Citation>Cal&#xf2; L.A., Fusaro M., Davis P.A. HO-1 attenuates hypertension-induced inflammation/oxidative stress: support from Bartter&#x2019;s/Gitelman&#x2019;s patients. Am. J. Hypertens. 2010;23(9):936&#x2013;936. doi: 10.1038/ajh.2010.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2010.130</ArticleId><ArticleId IdType="pubmed">20733571</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Leng B., Li Y., Jiang H., Duan W., Guo Y., Li C., Hong K. Diallyl trisulfide protects motor neurons from the neurotoxic protein TDP-43 via activating lysosomal degradation and the antioxidant response. Neurochem. Res. 2018;43(12):2304&#x2013;2312. doi: 10.1007/s11064-018-2651-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2651-3</ArticleId><ArticleId IdType="pubmed">30317421</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Islas C.A., Ch&#xe1;nez-C&#xe1;rdenas M.E., Barrera-Oviedo D., Ortiz-Plata A., Pedraza-Chaverri J., Maldonado P.D. Diallyl trisulfide protects rat brain tissue against the damage induced by ischemia-reperfusion through the Nrf2 pathway. Antioxidants. 2019;8(9):410. doi: 10.3390/antiox8090410.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8090410</ArticleId><ArticleId IdType="pmc">PMC6770608</ArticleId><ArticleId IdType="pubmed">31540440</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain K.K. In The Handbook of Neuroprotection. Springer; 2019. pp. 609&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9465-6_10</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P., M&#xf6;ller T. Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport. 2005;16(6):527&#x2013;531. doi: 10.1097/00001756-200504250-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200504250-00001</ArticleId><ArticleId IdType="pubmed">15812300</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P., Weiss M.D., M&#xf6;ller T., Carter G.T. Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosis. Curr. Opin. Investig. Drugs. 2002;3(12):1720&#x2013;1724.</Citation><ArticleIdList><ArticleId IdType="pubmed">12528305</ArticleId></ArticleIdList></Reference><Reference><Citation>Subedi L., Lee S.E., Madiha S., Gaire B.P., Jin M., Yumnam S., Kim S.Y. Phytochemicals against TNF&#x3b1;-mediated neuroinflammatory diseases. Int. J. Mol. Sci. 2020;21(3):764. doi: 10.3390/ijms21030764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21030764</ArticleId><ArticleId IdType="pmc">PMC7037901</ArticleId><ArticleId IdType="pubmed">31991572</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong W.Y., Farooqui T., Ho C.F.Y., Ng Y.K., Farooqui A.A. Use of Phytochemicals against neuroinflammation. Neuroprotective Effects of Phytochemicals in Neurological Disorders; 2017. p. 648.</Citation></Reference><Reference><Citation>Morita T. Celastrol: A new therapeutic potential of traditional Chinese medicine. Am. J. Hypertens. 2010;23(8):821&#x2013;821. doi: 10.1038/ajh.2010.87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2010.87</ArticleId><ArticleId IdType="pubmed">20644533</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiaei M., Kipiani K., Petri S., Chen J., Calingasan N.Y., Beal M.F. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis. 2005;2(5):246&#x2013;254. doi: 10.1159/000090364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000090364</ArticleId><ArticleId IdType="pubmed">16909005</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H.W., Chung Y.S., Kim Y.S., Park Y-K. Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells. Exp. Mol. Med. 2007;39(6):715&#x2013;721. doi: 10.1038/emm.2007.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2007.78</ArticleId><ArticleId IdType="pubmed">18160842</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesha S.H., Dudics S., Astry B., Moudgil K.D. Control of autoimmune inflammation by celastrol, a natural triterpenoid. Pathog. Dis. 2016;74(6):ftw059. doi: 10.1093/femspd/ftw059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femspd/ftw059</ArticleId><ArticleId IdType="pmc">PMC5985506</ArticleId><ArticleId IdType="pubmed">27405485</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Fotinos A., Mao L.L., Atassi N., Zhou E.W., Ahmad S., Guan Y., Berry J.D., Cudkowicz M.E., Wang X. Neuroprotective agents target molecular mechanisms of disease in ALS. Drug Discov. Today. 2015;20(1):65&#x2013;75. doi: 10.1016/j.drudis.2014.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2014.08.016</ArticleId><ArticleId IdType="pubmed">25205348</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Zhu Y., Dong X., Liu B., Zhang N., Wang X., Liu L., Xu C., Huang S., Chen L. Celastrol attenuates cadmium-induced neuronal apoptosis via inhibiting Ca2+ -CaMKII-dependent Akt/mTOR pathway. J. Cell. Physiol. 2017;232(8):2145&#x2013;2157. doi: 10.1002/jcp.25703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25703</ArticleId><ArticleId IdType="pmc">PMC9218942</ArticleId><ArticleId IdType="pubmed">27891586</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns J., Yokota T., Ashihara H., Lean M.E., Crozier A. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 2002;50(11):3337&#x2013;3340. doi: 10.1021/jf0112973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf0112973</ArticleId><ArticleId IdType="pubmed">12010007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi X.L., Yang J.Y., Dong Y.X., Wang J.M., Cui Y.H., Ikeshima T., Zhao Y.Q., Wu C.F. Resveratrol inhibits nitric oxide and TNF-&#x3b1; production by lipopolysaccharide-activated microglia. Int. Immunopharmacol. 2005;5(1):185&#x2013;193. doi: 10.1016/j.intimp.2004.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2004.08.008</ArticleId><ArticleId IdType="pubmed">15589480</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X-L., Yang J-Y., Chen G-L., Wang L-H., Zhang L-J., Wang S., Li J., Wu C-F. Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure-activity relationships. Chem. Biol. Interact. 2008;174(1):51&#x2013;59. doi: 10.1016/j.cbi.2008.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2008.04.015</ArticleId><ArticleId IdType="pubmed">18513711</ArticleId></ArticleIdList></Reference><Reference><Citation>Contestabile A. Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives. Curr. Top. Med. Chem. 2001;1(6):553&#x2013;568. doi: 10.2174/1568026013394723.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026013394723</ArticleId><ArticleId IdType="pubmed">11895131</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R., del Valle J., Modol L., Martinez A., Granado-Serrano A.B., Ramirez-N&#xfa;&#xf1;ez O., Pall&#xe1;s M., Portero-Otin M., Osta R., Navarro X. Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurotherapeutics. 2014;11(2):419&#x2013;432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3996124</ArticleId><ArticleId IdType="pubmed">24414863</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun Y.C., Jeong S.G., Kim S.H., Cho G.W. Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol. J. Tissue Eng. Regen. Med. 2019;13(1):110&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">30479062</ArticleId></ArticleIdList></Reference><Reference><Citation>ALS Untangled no. 49. Resveratrol. Amyotroph. Lateral Scler. Frontotemporal Degener. 2019;20(7-8):619&#x2013;624. doi: 10.1080/21678421.2019.1593596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1593596</ArticleId><ArticleId IdType="pubmed">30945567</ArticleId></ArticleIdList></Reference><Reference><Citation>Laudati G., Mascolo L., Guida N., Sirabella R., Pizzorusso V., Bruzzaniti S., Serani A., Di Renzo G., Canzoniero L.M.T., Formisano L. Resveratrol treatment reduces the vulnerability of SH-SY5Y cells and cortical neurons overexpressing SOD1-G93A to Thimerosal toxicity through SIRT1/DREAM/PDYN pathway. Neurotoxicology. 2019;71:6&#x2013;15. doi: 10.1016/j.neuro.2018.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2018.11.009</ArticleId><ArticleId IdType="pubmed">30503815</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiyan Y., Jianlan G., Dongmei Y., Qin S. Effect of curcumin on iNOS expression in LPS-activated microglia cells and anti-oxidation. 2010.</Citation></Reference><Reference><Citation>Yin W., Shi X., Zhang X., Yu L. Curcumins upregulate expression of HO-1 via inducing Nrf-2 in SH-SY5Y cells. Chinese Pharmacol. Bulletin, 2003.</Citation></Reference><Reference><Citation>Sikora E., Scapagnini G., Barbagallo M. Curcumin, inflammation, ageing and age-related diseases. Immun. Ageing. 2010;7(1):1. doi: 10.1186/1742-4933-7-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4933-7-1</ArticleId><ArticleId IdType="pmc">PMC2827376</ArticleId><ArticleId IdType="pubmed">20205886</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedlack R., Group A. ALSUntangled 44. Curcumin. Amyotroph. Lateral Scler. Frontotemporal Degener. 2018;19(7-8):623&#x2013;629. doi: 10.1080/21678421.2018.1440738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1440738</ArticleId><ArticleId IdType="pubmed">29493344</ArticleId></ArticleIdList></Reference><Reference><Citation>Chico L., Ienco E.C., Bisordi C., Gerfo A.L., Schirinzi E., Siciliano G. Curcumin as an ROS scavenger in amyotrophic lateral sclerosis. React. Oxygen Species. 2016;2(5):339&#x2013;354.</Citation></Reference><Reference><Citation>Adami R., Bottai D. Curcumin and neurological diseases. Nutr. Neurosci. 2020:1&#x2013;21. doi: 10.1080/1028415X.2020.1760531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2020.1760531</ArticleId><ArticleId IdType="pubmed">32441587</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan D., Ma B., Yang J.Y., Xie Y.Y., Wang L., Zhang L.J., Kano Y., Wu C.F. Anti-inflammatory effects of rhynchophylline and isorhynchophylline in mouse N9 microglial cells and the molecular mechanism. Int. Immunopharmacol. 2009;9(13-14):1549&#x2013;1554. doi: 10.1016/j.intimp.2009.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2009.09.010</ArticleId><ArticleId IdType="pubmed">19781666</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Liu J., Shi F., Lan Z., Li L., Ma S. Inhibitory effect of isorhynchophylline on lipopolysaccharide stimulated release of inflammatory mediators in primary rat astrocytes. Pharmacol Clin Res. 2011;19(2):311&#x2013;314.</Citation></Reference><Reference><Citation>Rahman M.A., Rahman M.R., Zaman T., Uddin M.S., Islam R., Abdel-Daim M.M., Rhim H. Emerging potential of naturally occurring autophagy Modulators against neurodegeneration. Curr. Pharm. Des. 2020;26(7):772&#x2013;779. doi: 10.2174/1381612826666200107142541.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612826666200107142541</ArticleId><ArticleId IdType="pubmed">31914904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ock J., Han H.S., Hong S.H., Lee S.Y., Han Y.M., Kwon B.M., Suk K. Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation. Br. J. Pharmacol. 2010;159(8):1646&#x2013;1662. doi: 10.1111/j.1476-5381.2010.00659.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2010.00659.x</ArticleId><ArticleId IdType="pmc">PMC2925488</ArticleId><ArticleId IdType="pubmed">20397299</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Su G., Gao J., Tian Y., Liu X., Zhang Z. Effects of peroxiredoxin 2 in neurological disorders: A review of its molecular mechanisms. Neurochem. Res. 2020;45(4):720&#x2013;730. doi: 10.1007/s11064-020-02971-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-02971-x</ArticleId><ArticleId IdType="pubmed">32002772</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehman M.U., Wali A.F., Ahmad A., Shakeel S., Rasool S., Ali R., Rashid S.M., Madkhali H., Ganaie M.A., Khan R. Neuroprotective strategies for neurological disorders by natural products: An update. Curr. Neuropharmacol. 2019;17(3):247&#x2013;267. doi: 10.2174/1570159X16666180911124605.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X16666180911124605</ArticleId><ArticleId IdType="pmc">PMC6425075</ArticleId><ArticleId IdType="pubmed">30207234</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng Y-T., Hsu Y-Y., Shih Y-T., Lo Y-C. Paeonol attenuates microglia-mediated inflammation and oxidative stress-induced neurotoxicity in rat primary microglia and cortical neurons. Shock. 2012;37(3):312&#x2013;318. doi: 10.1097/SHK.0b013e31823fe939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e31823fe939</ArticleId><ArticleId IdType="pubmed">22089194</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhu G., Yang S., Wang X., Cheng H., Wang F., Li X., Li Q. Paeonol prevents excitotoxicity in rat pheochromocytoma PC12 cells via downregulation of ERK activation and inhibition of apoptosis. Planta Med. 2011;77(15):1695&#x2013;1701. doi: 10.1055/s-0030-1271033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0030-1271033</ArticleId><ArticleId IdType="pubmed">21509715</ArticleId></ArticleIdList></Reference><Reference><Citation>He L.X., Tong X., Zeng J., Tu Y., Wu S., Li M., Deng H., Zhu M., Li X., Nie H., Yang L., Huang F. Paeonol suppresses neuroinflammatory responses in LPS-activated microglia cells. Inflammation. 2016;39(6):1904&#x2013;1917. doi: 10.1007/s10753-016-0426-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-016-0426-z</ArticleId><ArticleId IdType="pubmed">27624059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Kim Y.O., Kim H., Kim S.Y., Noh H.S., Kang S.S., Cho G.J., Choi W.S., Suk K. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J. 2003;17(13):1943&#x2013;1944. doi: 10.1096/fj.03-0057fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.03-0057fje</ArticleId><ArticleId IdType="pubmed">12897065</ArticleId></ArticleIdList></Reference><Reference><Citation>Piao H., Cui H., Piao R., Yingjun L. Effects of wogonin on LPS-induced production of proinflammatory cytokines. J. Xi&#x2019;an Jiaotong University. Medical Sciences; 1981. p. 2.</Citation></Reference><Reference><Citation>Zhang J., He Y., Jiang X., Jiang H., Shen J. Nature brings new avenues to the therapy of central nervous system diseases-An overview of possible treatments derived from natural products. Sci. China Life Sci. 2019;62(10):1332&#x2013;1367. doi: 10.1007/s11427-019-9587-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-019-9587-y</ArticleId><ArticleId IdType="pubmed">31444682</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Liu S., Zhang H., Zhou F., Liu Y., Lu Q., Yang L. Antioxidant effects of celastrol against hydrogen peroxide-induced oxidative stress in the cell model of amyotrophic lateral sclerosis. Sheng Li Xue Bao. 2017;69(6):751.</Citation><ArticleIdList><ArticleId IdType="pubmed">29270590</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane C.A., Brown I.R. Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol. Cell Stress Chaperones. 2016;21(5):837&#x2013;848. doi: 10.1007/s12192-016-0708-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-016-0708-2</ArticleId><ArticleId IdType="pmc">PMC5003800</ArticleId><ArticleId IdType="pubmed">27273088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer&#x2019;s disease and amyotrophic lateral sclerosis. EMBO J. 2007;26(13):3169&#x2013;3179. doi: 10.1038/sj.emboj.7601758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601758</ArticleId><ArticleId IdType="pmc">PMC1914106</ArticleId><ArticleId IdType="pubmed">17581637</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Zhang Y., Tang L., Zhang N., Fan D. Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis. Neurosci. Lett. 2011;503(3):250&#x2013;255. doi: 10.1016/j.neulet.2011.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2011.08.047</ArticleId><ArticleId IdType="pubmed">21896316</ArticleId></ArticleIdList></Reference><Reference><Citation>Markert C.D., Kim E., Gifondorwa D.J., Childers M.K., Milligan C.E. A single-dose resveratrol treatment in a mouse model of amyotrophic lateral sclerosis. J. Med. Food. 2010;13(5):1081&#x2013;1085. doi: 10.1089/jmf.2009.0243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2009.0243</ArticleId><ArticleId IdType="pubmed">20626250</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R., Del Valle J., Morell M., Pall&#xe1;s M., Osta R., Navarro X. Lack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G93A ALS mice: Overlapping effects or limited therapeutic opportunity? Orphanet J. Rare Dis. 2014;9(1):78. doi: 10.1186/1750-1172-9-78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-9-78</ArticleId><ArticleId IdType="pmc">PMC4035830</ArticleId><ArticleId IdType="pubmed">24885036</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H., Xu L., Wu L., Wang X., Duan W., Li H., Li C. Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS. Neuroscience. 2014;272:141&#x2013;153. doi: 10.1016/j.neuroscience.2014.04.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.04.032</ArticleId><ArticleId IdType="pubmed">24785678</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Hong Y.L., Xu D.S., Feng Y., Zhao L.J., Ruan K.F., Yang X.J. A review of experimental research on herbal compounds in amyotrophic lateral sclerosis. Phytother. Res. 2014;28(1):9&#x2013;21. doi: 10.1002/ptr.4960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.4960</ArticleId><ArticleId IdType="pubmed">23519768</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko Y., Coats A.B., Tuazon J.P., Jo M., Borlongan C.V. Rhynchophylline promotes stem cell autonomous metabolic homeostasis. Cytotherapy. 2020;22(2):106&#x2013;113. doi: 10.1016/j.jcyt.2019.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2019.12.008</ArticleId><ArticleId IdType="pubmed">31983606</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y-H., Zeng K-W. Natural products as a crucial source of anti-inflammatory drugs: Recent trends and advancements. Trad. Med. Res. 2019;4(5):257&#x2013;268.</Citation></Reference><Reference><Citation>Lee S-H., Suk K. Identification of glia phenotype modulators based on select glial function regulatory signaling pathways. Expert Opin. Drug Discov. 2018;13(7):627&#x2013;641. doi: 10.1080/17460441.2018.1465925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2018.1465925</ArticleId><ArticleId IdType="pubmed">29676181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Wang J. Wogonin increases &#x3b2;-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: Potential drug to treat Alzheimer&#x2019;s disease. Neurol. Sci. 2015;36(7):1181&#x2013;1188. doi: 10.1007/s10072-015-2070-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-015-2070-z</ArticleId><ArticleId IdType="pubmed">25596147</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousuf M., Khan P., Shamsi A., Shahbaaz M., Hasan G.M., Haque Q.M.R., Christoffels A., Islam A., Hassan M.I. Inhibiting CDK6 activity by quercetin is an attractive strategy for cancer therapy. ACS Omega. 2020;5(42):27480&#x2013;27491. doi: 10.1021/acsomega.0c03975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.0c03975</ArticleId><ArticleId IdType="pmc">PMC7594119</ArticleId><ArticleId IdType="pubmed">33134711</ArticleId></ArticleIdList></Reference><Reference><Citation>von Lewinski F., Keller B.U. Ca2+, mitochondria and selective motoneuron vulnerability: Implications for ALS. Trends Neurosci. 2005;28(9):494&#x2013;500. doi: 10.1016/j.tins.2005.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2005.07.001</ArticleId><ArticleId IdType="pubmed">16026864</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S.H., Beers D., Siklos L., Engelhardt J.I., Mosier D.R. Calcium: The darth vader of ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2001;2(1) Suppl. 1:S47&#x2013;S54.</Citation><ArticleIdList><ArticleId IdType="pubmed">11465925</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T., Lautenschl&#xe4;ger J., Grosskreutz J. Calcium-dependent protein folding in amyotrophic lateral sclerosis. Cell Calcium. 2013;54(2):132&#x2013;143. doi: 10.1016/j.ceca.2013.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2013.05.007</ArticleId><ArticleId IdType="pubmed">23764168</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D-M., Xiao L., Cai X., Zeng R., Zhu X-Z. Involvement of multitargets in paeoniflorin-induced preconditioning. J. Pharmacol. Exp. Ther. 2006;319(1):165&#x2013;180. doi: 10.1124/jpet.106.104380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.106.104380</ArticleId><ArticleId IdType="pubmed">16840647</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q.Q., Zhong X.M., Li Z.Y., Huang Z. Paeoniflorin protects against NMDA-induced neurotoxicity in PC12 cells via Ca2+ antagonism. Phytother. Res. 2011;25(5):681&#x2013;685. doi: 10.1002/ptr.3321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.3321</ArticleId><ArticleId IdType="pubmed">21043034</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., He L.N., He S.B. Effect of paeoniflorin on calcium overloading injury in cultured PC12 cells. Zhongguo Xin Yao Zazhi. 2001;6:413&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">12528512</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q-Q., Zhong X-M., Feng C-R., Pan A-J., Li Z-Y., Huang Z. Protective effects of paeoniflorin against glutamate-induced neurotoxicity in PC12 cells via antioxidant mechanisms and Ca(2+) antagonism. Cell. Mol. Neurobiol. 2010;30(7):1059&#x2013;1066. doi: 10.1007/s10571-010-9537-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-010-9537-5</ArticleId><ArticleId IdType="pubmed">20577899</ArticleId></ArticleIdList></Reference><Reference><Citation>da S Hage-Melim, L.I.; Ferreira, J.V.; de Oliveira, N.K.; Correia, L.C.; Almeida, M.R.; Poiani, J.G.; Taft, C.A.; de Paula da Silva, C.H. The impact of natural compounds on the treatment of neurodegenerative diseases. Curr. Org. Chem. 2019;23(3):335&#x2013;360.</Citation></Reference><Reference><Citation>Zhang L-C. Paeoniflorin reduces the spinal cord injury in rats through TLR4 inflammatory pathway and Nrf2 oxidative stress pathway: The experimental study. Hainan Yixueyuan Xuebao. 2017;23(8):26&#x2013;30.</Citation></Reference><Reference><Citation>Yifeng D., Zhaolin S., Yang L., Zhongyan H., Shuli S. Effects of ligustrazine on L-type calcium current in SH-SY5Y human neuroblastoma. Chinese J. Neuroimmunol. Neurol. 2004;11(1):43&#x2013;45.</Citation></Reference><Reference><Citation>Masoomzadeh S., Aminroaia P., Darchin Tabrizi F., Rashvand S., Rostamizadeh K. Lipid based nanoparticles for treatment of CNS diseases. Nanomed. Res. J. 2020;5(2):101&#x2013;113.</Citation></Reference><Reference><Citation>Li Y-M., Chen F-P., Liu G-Q. Studies on inhibitive effect of gastrodin on PC12 cell damage induced by glutamate and H~ 2O~ 2. Zhongguo Yaoke Daxue Xuebao. 2003;34(5):456&#x2013;460.</Citation></Reference><Reference><Citation>Xu X., Lu Y., Bie X. Protective effects of gastrodin on hypoxia-induced toxicity in primary cultures of rat cortical neurons. Planta Med. 2007;73(7):650&#x2013;654. doi: 10.1055/s-2007-981523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-981523</ArticleId><ArticleId IdType="pubmed">17583824</ArticleId></ArticleIdList></Reference><Reference><Citation>Du F., Wang X., Shang B., Fang J., Xi Y., Li A., Diao Y. Gastrodin ameliorates spinal cord injury via antioxidant and anti-inflammatory effects. Acta Biochim. Pol. 2016;63(3):589&#x2013;593. doi: 10.18388/abp.2016_1272.</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/abp.2016_1272</ArticleId><ArticleId IdType="pubmed">27474401</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun R., Zhang Z., Huang W., Lv L., Yin J. Protective effects and machanism of muskone on pheochromocytoma cell injure induced by glutamate. Zhongguo Zhongyao Zazhi. 2009;34(13):1701&#x2013;1704.</Citation><ArticleIdList><ArticleId IdType="pubmed">19873786</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Dewil M., Robberecht W., Van Den Bosch L. Excitotoxicity and amyotrophic lateral sclerosis. Neurodegener. Dis. 2005;2(3-4):147&#x2013;159. doi: 10.1159/000089620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000089620</ArticleId><ArticleId IdType="pubmed">16909020</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblum L.T. Trotti, D. Glial Amino Acid Transporters. Springer; 2017. pp. 117&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-55769-4_6</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik A.R., Willnow T.E. Excitatory amino acid transporters in physiology and disorders of the central nervous system. Int. J. Mol. Sci. 2019;20(22):5671. doi: 10.3390/ijms20225671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20225671</ArticleId><ArticleId IdType="pmc">PMC6888459</ArticleId><ArticleId IdType="pubmed">31726793</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J., Kim Y.H., Kong J-Y., Yang C.H., Park C.G. Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus. Life Sci. 2002;71(5):591&#x2013;599. doi: 10.1016/S0024-3205(02)01729-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0024-3205(02)01729-0</ArticleId><ArticleId IdType="pubmed">12052443</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Fang Y., Liang Y., Wang Q., He Y. Protective effects of &#x3b2;-asarone on PC12 cells damage induced by glutamate. Zhongguo Zhongyiyao Xinxi Zazhi. 2007;14:22&#x2013;23.</Citation></Reference><Reference><Citation>Zheng M., Fan D. Different distribution of NMDA receptor subunits in cortex contributes to selective vulnerability of motor neurons in amyotrophic lateral sclerosis. Beijing Da Xue Xue Bao. 2011;43(2):228&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">21503117</ArticleId></ArticleIdList></Reference><Reference><Citation>Deolankar S.C., Modi P.K., Subbannayya Y., Pervaje R., Prasad T.S.K. Molecular targets from traditional medicines for neuroprotection in human neurodegenerative diseases. OMICS. 2020;24(7):394&#x2013;403. doi: 10.1089/omi.2020.0033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2020.0033</ArticleId><ArticleId IdType="pubmed">32486962</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon R.K., Nigam S.V., Weitz J.A., Dave J.R., Doctor B.P., Ved H.S. The NMDA receptor ion channel: A site for binding of Huperzine A. J. Appl. Toxicol. 2001;21(S1) Suppl. 1:S47&#x2013;S51. doi: 10.1002/jat.805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jat.805</ArticleId><ArticleId IdType="pubmed">11920920</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemendinger R.A., Armstrong E.J., III, Persinski R., Todd J., Mougeot J-L., Volvovitz F., Rosenfeld J. Huperzine a provides neuroprotection against several cell death inducers using In-vitro model systems of motor neuron cell death. Neurotox. Res. 2008;13(1):49&#x2013;61. doi: 10.1007/BF03033367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03033367</ArticleId><ArticleId IdType="pubmed">18367440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S.S. Application of phytochemicals for the treatment of neurodegenerative diseases.Drug Invention Today, 2018;10(3)</Citation></Reference><Reference><Citation>Jiang B., Liu J.H., Bao Y.M., An L.J. Catalpol inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade. Toxicon. 2004;43(1):53&#x2013;59. doi: 10.1016/j.toxicon.2003.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2003.10.017</ArticleId><ArticleId IdType="pubmed">15037029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Kang B., Hu Y. XIA, Z.-q. Catalpol attenuates PC12 cells injury induced by L-glutamate. Zhongguo Yaolixue Tongbao. 2008;24:1258&#x2013;1259.</Citation></Reference><Reference><Citation>Zheng X-w., Yang W-t., Chen S., Xu Q-q., Shan C-s., Zheng G-q., Ruan J-c. Neuroprotection of catalpol for experimental acute focal ischemic stroke: Preclinical evidence and possible mechanisms of antioxidation, anti-inflammation, and antiapoptosis. Oxid. Med. Cell. Longev. 2017;2017:5058609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5530418</ArticleId><ArticleId IdType="pubmed">28785376</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Liu J-f., Xu K-p. ZOU, H.; SONG, L.-y.; DANG, R.-L.; ZOU, Z.-x.; LI, G.; TAN, G.-s. Chemical constituents in Selaginella tamariscina. Cent. South Pharm. 2011;9(8):564&#x2013;566.</Citation></Reference><Reference><Citation>Wang C-J., Hu C-P., Xu K-P., Yuan Q., Li F-S., Zou H., Tan G-S., Li Y-J. Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells. Naunyn Schmiedebergs Arch. Pharmacol. 2010;381(1):73&#x2013;81. doi: 10.1007/s00210-009-0470-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-009-0470-4</ArticleId><ArticleId IdType="pubmed">19936711</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Hern&#xe1;ndez J., Zald&#xed;var-Machorro V.J., Villanueva-Porras D., Vega-&#xc1;vila E., Chavarr&#xed;a A. A potential alternative against neurodegenerative diseases. Phytodrugs. Oxid. Med. Cell. Longev. 2016;2016:8378613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4736801</ArticleId><ArticleId IdType="pubmed">26881043</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi D., Ning W., Quan Z. Neuroprotective effects of ferulic acid against glutamate-induced neurotoxicity in PC12 cells. Pharmacol. Clin. Chinese Materia Medica; 2008. p. 6.</Citation></Reference><Reference><Citation>Jin Y., Yan E.Z., Fan Y., Guo X.L., Zhao Y.J., Zong Z.H., Liu Z. Neuroprotection by sodium ferulate against glutamate-induced apoptosis is mediated by ERK and PI3 kinase pathways. Acta Pharmacol. Sin. 2007;28(12):1881&#x2013;1890. doi: 10.1111/j.1745-7254.2007.00634.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-7254.2007.00634.x</ArticleId><ArticleId IdType="pubmed">18031600</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L., Sun Y. Neuroprotective effect of ferulic acid In-vitro. Zhong Yao Cai. 2011;34(11):1750&#x2013;1753.</Citation><ArticleIdList><ArticleId IdType="pubmed">22506403</ArticleId></ArticleIdList></Reference><Reference><Citation>Hole&#x10d;ek V., Rokyta R. Possible etiology and treatment of amyotrophic lateral sclerosis. Neuroendocrinol. Lett. 2018;38(8):528&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">29504729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Zheng W., Pi R., Mei Z., Bao Y., Gao J., Tang W., Chen S., Liu P. Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. Exp. Brain Res. 2009;193(1):109&#x2013;118. doi: 10.1007/s00221-008-1600-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-008-1600-9</ArticleId><ArticleId IdType="pubmed">18936923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Hashimoto Y., Kita Y., Sasabe J., Aiso S., Nishimoto I., Matsuoka M.A. Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. J. Biol. Chem. 2005;280(6):4532&#x2013;4543. doi: 10.1074/jbc.M410508200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M410508200</ArticleId><ArticleId IdType="pubmed">15579468</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X. Impaired tissue barriers as potential therapeutic targets for Parkinson&#x2019;s disease and amyotrophic lateral sclerosis. Metab. Brain Dis. 2018;33(4):1031&#x2013;1043. doi: 10.1007/s11011-018-0239-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-018-0239-x</ArticleId><ArticleId IdType="pubmed">29681010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran G. Insights on the neuromodulatory propensity of Selaginella (Sanjeevani) and its potential pharmacological applications. CNS Neurol. Disord. Drug Targets. 2014;13(1):82&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">24152330</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Zhang R., Li Y., Li Y., Yang Z., Yang H. Ferulic acid exerts neuroprotective effects against cerebral ischemia/reperfusion-induced injury via antioxidant and anti-apoptotic mechanisms in vitro and in vivo. Int. J. Mol. Med. 2017;40(5):1444&#x2013;1456. doi: 10.3892/ijmm.2017.3127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2017.3127</ArticleId><ArticleId IdType="pmc">PMC5627889</ArticleId><ArticleId IdType="pubmed">28901374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>